Home Antibody All anti-UBQLN4 antibodies
Also for UBQLN4 (NM_020131)
|CIP75 antibody was raised against an 18 amino acid peptide near the amino terminus of human CIP75.|
|Human, Mouse, Rat
||WB: 1 - 2 ug/ml
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens ubiquilin 4 (UBQLN4), transcript variant 1|
|A1U; A1Up; C1orf6; CIP75; UBIN|
Entrez Gene 56893 Human
Entrez Gene 94232 Mouse
Entrez Gene 310633 Rat
|The ubiquitin-proteosome pathway of protein degradation is one of the mechanisms that ensure the proper level of cellular proteins. The ubiquitin-like (UbL) and ubiquitin-associated (UBA) domain containing protein family is thought to be involved in proteosomal degradation. One such protein is CIP75, also known as ubiquilin-4, interacts with a number of proteins such as Ataxin-1 and Connexin-43, resulting in an increased rate of turnover of these proteins. Overexpression CIP75 led to a significant reduction of Connexin-43 half-life, with the opposite being observed in siRNA knockdown experiments. CIP75 contains an N-terminal UbL domain which is thought to interact with proteins of the 26S proteosome complex and a C-terminal UBA domain which appears to mediate its interaction with Connexin-75. At least three isoforms of CIP75 are known to exist.|
|Druggable Genome |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of CIP75 in 3T3 cell lysate with CIP75 antibody at (A) 1 and (B) 2 ug/ml.
Immunohistochemistry of CIP75 in mouse kidney tissue with CIP75 antibody at 5 ug/ml.